EN DE

Q & M DENTAL GROUP (S) LIMITED (QC7) Fair Value & Analysis

Healthcare · SG · Market cap 521M SGD

QM Q & M DENTAL GROUP (S) LIMITED QC7 · SG
Price0.5600 SGD
Fair Value0.2200 SGD
Upside-60.7%
Quality60/100
Watch Q & M DENTAL GROUP (S) LIMITED for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 4.7% net margin
Moderate debt · generates free cash flow
1.45% dividend yield
Trails peers (5/15)
Narrow moat 43/100
Evidence: Medium Range 0.1600 SGD – 0.2700 SGD Share as image

Fair value as of: Aug 13, 2026

From 25 valuation models · updated 4 days ago

Share price +3.7% over the past month.

A solid business, but screening 61% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (0.2700 SGD). The favourable scenario is already priced in.
  • Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

0.6350 SGD 0.1988 SGD Fair Value 0.2200 SGD May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range 0.1988 SGD – 0.6350 SGD · fair‑value band 0.1600 SGD – 0.2700 SGD · the 0.5600 SGD price screens above the 0.2200 SGD fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Q & M DENTAL GROUP (S) LIMITED (QC7) currently trades at 0.5600 SGD, while our model-based Fair Value estimate is 0.2200 SGD, implying the stock looks roughly 60.7% overvalued today. The Quality Score stands at 60/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Q & M DENTAL GROUP (S) LIMITED generated revenue of 197M SGD at a net margin of 4.7%. Revenue grew 18.5% year over year. It earns a return on equity of 8.1%. Net debt stands at 26.3M SGD. Fundamentals as of Aug 13, 2026

Our scenario range runs from 0.1600 SGD (bear case) to 0.2700 SGD (bull case); at 0.5600 SGD, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 12% below its 52-week high and 46% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at -61%, QC7 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 0.2800 SGD 0.3800 SGD 0.5000 SGD 80
Residual Income 0.0900 SGD 0.1000 SGD 0.1000 SGD 76
Rev-Margin DCF 0.2200 SGD 0.3300 SGD 0.4500 SGD 74
All 25 models by family
DCF Models
FCF DCF 0.2800 SGD 0.3900 SGD 0.5300 SGD 38
Owner Earnings 0.2000 SGD 0.2900 SGD 0.3900 SGD 31
5Y Revenue Exit 0.2200 SGD 0.3300 SGD 0.4600 SGD 39
5Y EBITDA Exit 0.3400 SGD 0.5400 SGD 0.7800 SGD 41
5Y P/E Exit 0.1800 SGD 0.2600 SGD 0.3400 SGD 38
10Y Revenue Exit 0.2300 SGD 0.3300 SGD 0.4500 SGD 36
10Y EBITDA Exit 0.3100 SGD 0.4700 SGD 0.6600 SGD 37
10Y P/E Exit 0.2200 SGD 0.2900 SGD 0.3700 SGD 35
Earnings-Based
Graham-Dodd 0.0700 SGD 0.1700 SGD 0.2200 SGD 54
PEG = 1.0 0.0300 SGD 0.0400 SGD 0.0600 SGD 46
EPV 0.1400 SGD 0.1700 SGD 0.1900 SGD 59
Dividend Discount
Gordon GGM 0.0900 SGD 0.1400 SGD 0.2100 SGD 70
DDM Multi-Stage 0.0900 SGD 0.1200 SGD 0.1600 SGD 61
Multiples
P/E Multiple 0.1600 SGD 0.2200 SGD 0.2700 SGD 63
P/S Multiple 0.1300 SGD 0.1700 SGD 0.2100 SGD 58
P/B Multiple 0.1300 SGD 0.1700 SGD 0.2100 SGD 55
EV/EBIT 0.2800 SGD 0.3800 SGD 0.4800 SGD 53
EV/EBITDA 0.4400 SGD 0.6000 SGD 0.7600 SGD 54
EV/Revenue 0.1900 SGD 0.2900 SGD 0.3800 SGD 43
Asset-Based
NCAV (Graham) 0.0600 SGD 0.0700 SGD 0.1100 SGD 50
Growth DCF
Growth DCF 0.2800 SGD 0.3800 SGD 0.5000 SGD 80
Rev-Margin DCF 0.2200 SGD 0.3300 SGD 0.4500 SGD 74
Economic Profit
Residual Income 0.0900 SGD 0.1000 SGD 0.1000 SGD 76
ROIC Compounder 0.1500 SGD 0.1800 SGD 0.2200 SGD 72
Growth Earnings
Growth-Adj P/E 0.1200 SGD 0.1800 SGD 0.2300 SGD 68

Widest divergence: DCF Models (0.3300 SGD) versus Asset-Based (0.0700 SGD). Highest evidence: Growth DCF (80).

Notify me when QC7 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 197M SGD
Revenue growth (YoY) +18.5%
Net margin 4.7%
Return on equity 8.1%
Free cash flow 31.9M SGD FY2025
P/E ratio 56.0
More key figures
Operating margin 10.1%
EPS (TTM) 0.0100 SGD
Dividend yield 1.5%
EPS growth (YoY) +18.1%
Net debt 26.3M SGD FY2025

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 60/100

Of which business quality 60 · Market factors (momentum, volatility) 60

Profitability 45
Margins and returns on capital today
Quality Growth 20
Are margins and returns improving?
Cashflow 81
Earnings quality: real cash, not paper profit
Fin. Strength 57
Balance sheet, leverage, solvency risk
Investment 79
Disciplined investing over empire-building
Low Volatility 73
Calm price path (market factor)
Momentum 48
Price trend over the last 3–12 months (market factor)
52W Momentum 65
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Q & M Dental Group (Singapore) Limited, an investment holding company, provides private dental healthcare services in Singapore, Malaysia, and China.

Full company description

Q & M Dental Group (Singapore) Limited, an investment holding company, provides private dental healthcare services in Singapore, Malaysia, and China. It offers various aesthetic/cosmetic, pediatric, CAD CAM digital, children, clear aligner, and implant dentistry services; consultation, gum disease and surgery, intraoral 3D scanning, oral surgery, root canal treatment, scaling and polishing, teeth grinding and whitening, tooth-coloured filling, and wisdom tooth surgery services; and crowns and bridges, dental X-rays and AI scan, dentures, extractions, mouth and night guards, orthodontics, and sensitive teeth. The company also provides general health services, including adult and children consultation, chronic disease management, men's health, and skin care services; cervical PAP smear, family planning, general and pre-marital health screening, smoking cessation, and weight loss management services; and cervical cancer, chicken pox, childhood, hepatitis profiling, tetanus, typhoid, influenza, and travel advice and vaccinations. In addition, it offers pre-education/extracurricular activity certifications, and pre-employment checks; and ear syringing, draining of abscess, foreign materials and warts removal, suturing, and wound care and dressing services. Further, the company provides laboratory testing services; and Covid-19 test kits, as well as higher education programmes to dentists. Additionally, it trades in dental surgery materials and equipment; develops dental healthcare software and equipment; and operates dental and medical outlets, and a dental college. The company was founded in 1996 and is headquartered in Singapore. Q & M Dental Group (Singapore) Limited operates as a subsidiary of Quan Min Holdings Pte. Ltd.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Q & M DENTAL GROUP (S) LIMITED reported revenue of 197M SGD in FY2025 versus 205M SGD in FY2021, a compound −1.0%/yr. Reported net income was 9.3M SGD in FY2025, compounding −25.6%/yr from FY2021.

Growth Quality 75/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
197M SGD
Latest YoY
+9.2%
Avg. growth/yr (3Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.9%
Avg. growth/yr (5Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.5%
Avg. growth/yr (12Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.9%
Revenue −1.0%/yr
FY21 205M SGD
FY22 181M SGD
FY23 183M SGD
FY24 181M SGD
FY25 197M SGD
Net income −25.6%/yr
FY21 30.5M SGD
FY22 11.3M SGD
FY23 11.5M SGD
FY24 14.3M SGD
FY25 9.3M SGD

QC7 screens 61% overvalued. Compare with HCA Healthcare, Inc →

Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Q & M DENTAL GROUP (S) LIMITED · Fair Value
0.2200 SGD −61%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Q & M DENTAL GROUP (S) LIMITED Fair Value". https://www.fairvalue-calculator.com/stock/QC7

Peer Group

Medical Care Facilities · 267 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 60 · Above median
Fair Value upside −61% · Bottom 25%
Return on equity (TTM) 8% · Above median
Return on assets 5% · Above median
Net margin (TTM) 5% · Below median
Operating margin (TTM) 10% · Above median
Revenue growth 19% · Top 25%
Dividend yield (TTM) 1.5% · Below median
Debt / equity 1.37× · Higher than 75% of peers

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/E (TTM) 56.0× · Pricier than 75% of peers
P/B 3.91× · Pricier than 75% of peers
P/S (TTM) 2.07× · Pricier than 75% of peers
P/FCF 12.8× · Pricier than 75% of peers
EV/EBITDA 15.4× · Pricier than 75% of peers
PEG 1.97× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 27
FUTURE 93 · sector 23
PAST 33 · sector 29
HEALTH 32 · sector 90
DIVIDEND 29 · sector 41

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $414.59 $547.67 +32%
Fresenius SE FRE €46.82 €32.15 -31%
Dr. Sulaiman Al Habib Medical Services Group 4013 235.00 SAR 112.37 SAR -52%
IHH Healthcare Berhad, an investment holding company, Q0F 2.67 SGD 1.44 SGD -46%
Tenet Healthcare Corporation THC $266.79 $330.25 +24%
Rede D'Or São Luiz S.A RDOR3 R$33.97 R$47.31 +39%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,565 ₹2,955 -65%
Aier Eye Hospital Group 300015 ¥8.87 ¥7.67 -14%
Max Healthcare Institute Limited MAXHEALTH ₹1,008 ₹284.87 -72%
Bangkok Dusit Medical Services Public Company BDMS 19.70 THB 18.57 THB -6%

Compare Q & M DENTAL GROUP (S) LIMITED with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Q & M DENTAL GROUP (S) LIMITED (QC7) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of 0.2200 SGD versus a price of 0.5600 SGD, about −61% (overvalued).
What is the fair value of QC7?
Our model-based fair value for Q & M DENTAL GROUP (S) LIMITED is 0.2200 SGD (as of Aug 13, 2026), built from audited fundamentals. The current price is 0.5600 SGD.
What is the quality score of QC7?
Q & M DENTAL GROUP (S) LIMITED has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Q & M DENTAL GROUP (S) LIMITED (QC7)?
Q & M DENTAL GROUP (S) LIMITED reported trailing-twelve-month revenue of about 197M SGD (latest available figure, as of Aug 13, 2026).
What is the net profit margin of QC7?
The net profit margin of Q & M DENTAL GROUP (S) LIMITED is about 4.7%, meaning it keeps roughly 4.7% of revenue as net income. Based on the latest reported figures.
Does Q & M DENTAL GROUP (S) LIMITED pay a dividend?
Q & M DENTAL GROUP (S) LIMITED currently shows a dividend yield of about 1.45% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Q & M DENTAL GROUP (S) LIMITED and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.